Core Viewpoint - The company has received a medical device registration certificate for its Immunoglobulin G (IgG) assay kit, which is expected to positively impact its development but will not significantly affect recent production or performance [1] Group 1: Product Development - The product is an IgG assay kit using latex immunoturbidimetry, designed for the quantitative measurement of IgG levels in human urine [1] - This new product enriches the company's biochemical testing product line in the "renal function" category [1] Group 2: Market Impact - The approval of the medical device registration certificate is anticipated to have a positive influence on the company's growth [1] - However, it is noted that there will be no major impact on the company's recent operations and financial performance [1]
新产业:免疫球蛋白G测定试剂盒(胶乳免疫比浊法)获得医疗器械注册证